ViviCells International, Inc. (VCII)

ViviCells International Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 1999	FY 1998	FY 1997
Period Ending	Dec 31, 1999	Dec 31, 1998	Dec 31, 1997
Net Income	-0.01	-0.18	-0.32
Depreciation & Amortization	0.03	0.07	0.05
Asset Writedown & Restructuring Costs	0.06	0.41	-
Stock-Based Compensation	0.05	0.02	-
Other Operating Activities	0.26	0.08	-0
Change in Accounts Receivable	-1.16	-1.66	-0.63
Change in Inventory	-0.53	-0.55	-0.49
Change in Accounts Payable	-0.09	-0.14	0.26
Change in Income Taxes	0.23	0.1	-
Change in Other Net Operating Assets	-0.04	0.04	0.04
Operating Cash Flow	-1.21	-1.82	-1.08
Capital Expenditures	-0.05	-0.03	-0.03
Investing Cash Flow	-0.05	-0.03	-0.03
Long-Term Debt Issued	1.3	1.26	1.08
Long-Term Debt Repaid	-0.06	-0.02	-0.05
Net Debt Issued (Repaid)	1.24	1.24	1.02
Issuance of Common Stock	0.09	0.6	0.08
Other Financing Activities	-0.05	-	-
Financing Cash Flow	1.28	1.84	1.1
Net Cash Flow	0.02	-0.01	-0
Free Cash Flow	-1.26	-1.85	-1.11
Free Cash Flow Margin	-33.39%	-52.46%	-61.16%
Cash Interest Paid	0.04	0.04	0.03
Levered Free Cash Flow	-1.42	-	-
Unlevered Free Cash Flow	-1.1	-	-
Change in Net Working Capital	1.58	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.